Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 4, 2010, Pages 766-772

  Nobécourt, Estelle ^a   Tabet, Fatiha ^a   Lambert, Gilles ^a,c   Puranik, Rajesh ^a,d   Bao, Shisan ^a,e   Yan, Ling ^a   Davies, Michael J ^b,c   Brown, Bronwyn E ^b   Jenkins, Alicia J ^f   Dusting, Gregory J ^g   Bonnet, David J ^h   Curtiss, Linda K ^h   Barter, Philip J ^a,d   Rye, Kerry Anne ^a,d,f  

^a Lipid Research Group   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITÉ DE NANTES   (France)

^d Faculty of Medicine   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f O'Brien Institute   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adhesion molecules; ApoA I; HDL; Inflammation; Neutrophils; NF B; Reactive oxygen species

Indexed keywords

APOLIPOPROTEIN A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; METHYLGLYOXAL; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; APOA1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GLYCATION; INFLAMMATION; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; VASCULAR ENDOTHELIUM; ACTIVE TRANSPORT; ANIMAL; CAROTID ARTERY INJURY; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; DISEASE MODEL; GLYCOSYLATION; HUMAN; IMMUNOLOGY; INFUSION; METABOLISM; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHORYLATION; PROTEIN PROCESSING; TIME;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEIN A-I; CAROTID ARTERIES; CAROTID ARTERY INJURIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; GLYCOSYLATION; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INFUSIONS, PARENTERAL; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, HDL; NEUTROPHIL INFILTRATION; NF-KAPPA B; PHOSPHATIDYLCHOLINES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRUVALDEHYDE; RABBITS; REACTIVE OXYGEN SPECIES; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77950880808     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.201715     Document Type: Article

References (33)

1. Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res. 1999;40:345-353.
2. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:1987-1994.
3. Cockerill GW, Huehns TY, Weerasinghe A, Stocker C, Lerch PG, Miller NE, Haskard DO. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation. 2001;103:108-112.
4. Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, Stewart KN, Cuzzocrea S, Britti D, Mota-Filipe H, Chatterjee PK. High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J Am Soc Nephrol. 2003;14:1833-1843.
5. Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, Rye KA, Barter PJ. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation. 2005;111:1543-1550.
6. Puranik R, Bao S, Nobecourt E, Nicholls SJ, Dusting GJ, Barter PJ, Celermajer DS, Rye KA. Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis. 2008;196:240-247.
7. Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005;111:2446-2453.
8. Marfella R, Esposito K, Giunta R, Coppola G, De Angelis L, Farzati B, Paolisso G, Giugliano D. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation. 2000;101:2247-2251.
9. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes. 1997;46:2096-2101.
10. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006;55:774-779.
11. Curtiss LK, Witztum JL. Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes. 1985;34:452-461.
12. Shishino K, Murase M, Makino H, Saheki S. Glycated apolipoprotein A-I assay by combination of affinity chromatography and latex immunoag-glutination. Ann Clin Biochem. 2000;37:498-506.
13. Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methyl-glyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999;344:109-116.
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
15. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA. 1994;91:9441-9445.
16. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274:31740-31749.
17. Kunt T, Forst T, Harzer O, Buchert G, Pfutzner A, Lobig M, Zschabitz A, Stofft E, Engelbach M, Beyer J. The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp Clin Endocrinol Diabetes. 1998;106:183-188.
18. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395-1403.
19. Hedrick CC, Thorpe SR, Fu MX, Harper CM, Yoo J, Kim SM, Wong H, Peters AL. Glycation impairs high-density lipoprotein function. Diabetologia. 2000;43:312-320.
20. Nobecourt E, Davies MJ, Brown BE, Curtiss LK, Bonnet DJ, Charlton F, Januszewski AS, Jenkins AJ, Barter PJ, Rye KA. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:choles-terol acyltransferase. Diabetologia. 2007;50:643-653.
21. Nobecourt E, Zeng J, Davies MJ, Brown BE, Yadav S, Barter PJ, Rye KA. Effects of cross-link breakers, glycation inhibitors and insulin sen-sitisers on HDL function and the non-enzymatic glycation of apoli-poprotein A-I. Diabetologia. 2008;51:1008-1017.
22. Tabet F, Remaley AT, Segaliny AI, Millet J, Yan L, Nakhla S, Barter PJ, Rye KA, Lambert G. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro. Arte-rioscler Thromb Vasc Biol. 2009. In press.
23. Patel S, Puranik R, Nakhla S, Lundman P, Stocker R, Wang XS, Lambert G, Rye KA, Barter PJ, Nicholls SJ, Celermajer DS. Acute hypertriglyc-eridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis. 2008;204:424-428.
24. De Souza JA, Vindis C, Hansel B, Negre-Salvayre A, Therond P, Serrano CV, Jr., Chantepie S, Salvayre R, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apo-ptotic activity. Atherosclerosis. 2008;197:84-94.
25. Kontush A, Chapman MJ. Why is HDL functionally deficient in type 2 diabetes? Curr Diab Rep. 2008;8:51-59.
26. Shu HB, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T, Nabel GJ. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endo-thelial and epithelial cells. Mol Cell Biol. 1993;13:6283-6289.
27. Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, Ludwig S, Wirth T. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem. 2001;276:28451-28458.
28. Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HW, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arte-rioscler Thromb. 1994;14:1665-1673.
29. Park SH, Park JH, Kang JS, Kang YH. Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol. 2003;35:168-182.
30. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999;66:876-888.
31. Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, Schmidt AM, Stern DM, Al-Mohanna FA. RAGE-mediated neu-trophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol. 2002;71:433-444.
32. Vlassara H, Fuh H, Donnelly T, Cybulsky M. Advanced glycation end-products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1995;1:447-456.
33. Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, Danze PM, Dequiedt P. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 2002;61:148-156.